Salsolinol-1-carboxylic acidEndogenous amino acid CAS# 57256-34-5 |
2D Structure
- Guanfacine hydrochloride
Catalog No.:BCC1609
CAS No.:29110-48-3
- (R,R)-Formoterol
Catalog No.:BCC1293
CAS No.:67346-49-0
- Doxazosin Mesylate
Catalog No.:BCC1257
CAS No.:77883-43-3
- Medetomidine
Catalog No.:BCC1736
CAS No.:86347-14-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 57256-34-5 | SDF | Download SDF |
PubChem ID | 100185 | Appearance | Powder |
Formula | C11H13NO4 | M.Wt | 223.23 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 25 mM in water | ||
Chemical Name | 6,7-dihydroxy-1-methyl-3,4-dihydro-2H-isoquinoline-1-carboxylic acid | ||
SMILES | CC1(C2=CC(=C(C=C2CCN1)O)O)C(=O)O | ||
Standard InChIKey | XHGLVMDBZZZXDP-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H13NO4/c1-11(10(15)16)7-5-9(14)8(13)4-6(7)2-3-12-11/h4-5,12-14H,2-3H2,1H3,(H,15,16) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | An amino acid that occurs naturally in the CNS. |
Salsolinol-1-carboxylic acid Dilution Calculator
Salsolinol-1-carboxylic acid Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.4797 mL | 22.3984 mL | 44.7968 mL | 89.5937 mL | 111.9921 mL |
5 mM | 0.8959 mL | 4.4797 mL | 8.9594 mL | 17.9187 mL | 22.3984 mL |
10 mM | 0.448 mL | 2.2398 mL | 4.4797 mL | 8.9594 mL | 11.1992 mL |
50 mM | 0.0896 mL | 0.448 mL | 0.8959 mL | 1.7919 mL | 2.2398 mL |
100 mM | 0.0448 mL | 0.224 mL | 0.448 mL | 0.8959 mL | 1.1199 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 7-Ethoxyresorufin
Catalog No.:BCC6476
CAS No.:5725-91-7
- Methoxyresorufin
Catalog No.:BCC6296
CAS No.:5725-89-3
- Pamidronate Disodium
Catalog No.:BCC1193
CAS No.:57248-88-1
- H-Phe(3-CN)-OH
Catalog No.:BCC3182
CAS No.:57213-48-6
- Testosterone decanoate
Catalog No.:BCC9168
CAS No.:5721-91-5
- Ayanin
Catalog No.:BCN4056
CAS No.:572-32-7
- Engeletin
Catalog No.:BCN5772
CAS No.:572-31-6
- Avicularin
Catalog No.:BCN5771
CAS No.:572-30-5
- Neosenkirkine
Catalog No.:BCN2138
CAS No.:57194-70-4
- Paxilline
Catalog No.:BCC7235
CAS No.:57186-25-1
- Naftopidil DiHCl
Catalog No.:BCC4355
CAS No.:57149-08-3
- Naftopidil
Catalog No.:BCC4352
CAS No.:57149-07-2
- Setiptiline
Catalog No.:BCC1945
CAS No.:57262-94-9
- Calmidazolium chloride
Catalog No.:BCC7410
CAS No.:57265-65-3
- Boc-D-Phe(4-Cl)-OH
Catalog No.:BCC3176
CAS No.:57292-44-1
- Boc-D-Phe(4-F)-OH
Catalog No.:BCC3218
CAS No.:57292-45-2
- Ridaforolimus (Deforolimus, MK-8669)
Catalog No.:BCC4605
CAS No.:572924-54-0
- Boehmenan
Catalog No.:BCN5773
CAS No.:57296-22-7
- Liriodendrin
Catalog No.:BCN5774
CAS No.:573-44-4
- Congo Red
Catalog No.:BCC8023
CAS No.:573-58-0
- Tacalcitol
Catalog No.:BCC1975
CAS No.:57333-96-7
- Dihydroepistephamiersine 6-acetate
Catalog No.:BCN5775
CAS No.:57361-74-7
- Bombinakinin-GAP
Catalog No.:BCC5903
CAS No.:573671-91-7
- Isochlorogenic acid C
Catalog No.:BCN2498
CAS No.:57378-72-0
Oxidative decarboxylation of salsolinol-1-carboxylic acid to 1,2-dehydrosalsolinol: evidence for exclusive catalysis by particulate factors in rat kidney.[Pubmed:3369867]
Arch Biochem Biophys. 1988 May 15;263(1):86-95.
The decarboxylation of Salsolinol-1-carboxylic acid (1-methyl-6,7-dihydroxy-1,2,3,4- tetrahydroisoquinoline-1-carboxylic acid), a novel endogenous catecholic adduct of dopamine and pyruvic acid, was examined in nuclei-free homogenates of rat liver, whole brain, and kidney, as well as in buffer only. Liquid chromatographic analysis of incubations for varying times (30 min to 5 h) showed that the tetrahydroisoquinoline substrate decarboxylated oxidatively, forming one product, 1-methyl-6,7-dihydroxy-3,4-dihydroisoquinolines (1,2-dehydrosalsolinol). No salsolinol was apparent, even with added NADPH. In buffer, decarboxylation occurred by an apparent oxygen radical-mediated process: it was stimulated by cupric ion or elevated pH, and was suppressed by EDTA, superoxide dismutase, metal ion removal with Chelex-100, or low pH (less than 6). In liver or brain, the conversion was qualitatively and quantitatively similar to that in buffer; thus there was no evidence for enzyme involvement. In kidney, however, dehydrosalsolinol formation was significantly greater than that in liver, brain, or buffer, and preboiling reduced it nearly to buffer values. The heat-labile kidney activity, displaying a pH maximum ca. 9, was localized in the particulate fractions. It was blocked completely by N-ethylmaleimide. Added superoxide dismutase was only slightly inhibitory; catalase and dimethyl sulfoxide, a hydroxyl radical trap, were uneffective. Lack of inhibition by indomethacin ruled against peroxidative involvement of kidney prostaglandin synthetase. Physiological amounts of a cofactor for amino acid decarboxylases, pyridoxal-5'-phosphate, also had no effect. The oxidative decarboxylation of 1-carboxylated salsolinol by kidney fractions appears mainly due to a sulfhydryl-containing particulate factor unique to or relatively concentrated in that organ. Its identity, substrate specificity, and possible significance, particularly in alcoholism, where elevated Salsolinol-1-carboxylic acid levels have been reported, remain to be ascertained.
Oxidation chemistry of the endogenous central nervous system alkaloid salsolinol-1-carboxylic acid.[Pubmed:8421275]
J Med Chem. 1993 Jan 8;36(1):11-20.
The oxidation chemistry of Salsolinol-1-carboxylic acid (1), an alkaloid endogenous to the central nervous system which is elevated as a result of ethanol consumption, has been studied by electrochemical approaches at pH 7.0 in aqueous solution. The first voltammetric oxidation peak of Ia of 1 at pH 7.0 occurs at Ep = +0.116 V, indicating that this alkaloid is a very easily oxidized compound. The peak Ia reaction is a 2e-2H+ oxidation of 1 to 1,2,3,4-tetrahydro-1-methyl-1-carboxy-6,7-isoquinolinedione (8), which rapidly decarboxylates (k > 10(3) s-1) to give predominantly the quinone methide tautomer of 3,4-dihydro-1-methyl-6,7-isoquinolinediol (2). The latter compound is responsible for the second observed oxidation peak IIa observed with 1. This peak is a 2e oxidation of 2 to a quinoid intermediate (9) which can either be attacked by water to yield 3,4-dihydro-1-methyl-5,7-dihydroxyisoquinolin-6-one (13b) (which is readily further oxidized to 3,4-dihydro-1-methyl-5-hydroxyisoquinoline-6,7-dione (3)) or aromatizes to yield 1-methyl-6,7-isoquinolinediol (4). Preliminary in vivo experiments have revealed that 2 and 13b are behavioral toxins when injected into the brains of laboratory mice. The in vitro oxidation reactions of 1 and 2 reported here might be of relevance to the neurodegenerative, behavioral, and addictive consequences of chronic alcoholism.
Identification and quantification of 1-carboxysalsolinol and salsolinol in biological samples by gas chromatography--mass spectrometry.[Pubmed:4066844]
J Chromatogr. 1985 Sep 13;343(1):1-8.
1-Carboxysalsolinol was found to be present in rat striatum, human urine and caudate nucleus of post mortem human brain, according to capillary column gas chromatographic retention times and selected ion monitoring of the hexafluoropropionyl ester pentafluoropropyl derivative. Simultaneous quantification of 1-carboxysalsolinol and salsolinol was performed in biological samples using deuterium labelled internal standards. In human urine, the precision of the method was +/- 7.1% (coefficient of variation, n = 25) for 1-carboxysalsolinol at 15 pmol/ml and +/- 8.5% for salsolinol at 10 pmol/ml. According to enzymatic hydrolysis, 68% of 1-carboxysalsolinol was found as conjugates in urine, and the corresponding figure for salsolinol was 92%. In human caudate nucleus, the amounts of 1-carboxysalsolinol were found to be significantly greater in brains from alcoholics, who at autopsy had ethanol present in the blood, whereas alcoholics without blood ethanol levels at autopsy had significantly lower concentrations of salsolinol.